Eva Colas Ortega

I am principal researcher in the Group of Biomedical Research in Gynecology, where I lead the translational research group. My research interest is to provide solutions for unmet clinical needs in gynecology, mainly in endometrial cancer and endometriosis. We work on biomarker research to provide with innovative solutions and preclinical models to improve personalized medicine.

Institutions of which they are part

Head of group
Biomedical Research in Gynaecology

Vall Hebron Institut de Recerca

Eva Colas Ortega

Institutions of which they are part

Head of group
Biomedical Research in Gynaecology

Vall Hebron Institut de Recerca

I am biologist by formation and fully dedicated to endometrial cancer research for the last 16 years. From 2017, I lead my own team in the Group of Biomedical Research in Gynecology (VHIR) and my research focus on the implementation of molecular diagnostics and personalized medicine in gynecology, mainly in endometrial cancer (EC) and endometriosis.
In my career I participated in the development of the first EC patient-derived murine models (PDX), and today, my group owns one of the largest PDX biobanks in Europe, which is used by us, partners and pharma to assess treatments for EC patients. Importantly, I have also grown as a scientist dedicated to biomarker research in gynecological fluids. I worked in the development of the first molecular kit to diagnose EC. Today, I am the European Coordinator of a multicenter study to develop a non-invasive diagnosis of EC (ERA PerMed), and am the founder of a spin-off (MiMARK Diagnostics S.L.) that aims to develop innovative solutions for women health.
As a summary, I have a total of 73 scientific articles with impact factor; 17 of them as senior author; and am inventor of 4 patents. My scientific and leadership capacity is proved by the supervision of 12 doctoral theses, 6 of which have already been defended, two of them awarded. I have participated in 32 competitive research projects, being 13 of them principal investigator, and I am actively participating in national (CIBERONC) and international (ENITEC) cancer networks.
I have been teaching in graduate and master studies for the last 7 years; and I have been on the Steering Committee of the Societat Catalana de Biologia for 10 years.

Projects

ProstatePredict. Desarrollo de una prueba de pronóstico para predecir la probabilidad de enfermedad agresiva después de la cirugía

IP: Jaume Reventós Puigjaner
Collaborators: Eva Colas Ortega
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 150405
Reference: IPT-2012-1311-300000
Duration: 17/12/2012 - 30/04/2016

Red Temática de Investigación Cooperativa en Cáncer - RTICC

IP: Jaume Reventós Puigjaner
Collaborators: Joan Morote Robles, Inés de Torres Ramirez, Maria Asuncion Perez Benavente, Eva Colas Ortega, Silvia Cabrera Diaz, Antonio Gil Moreno, Marina Rigau Resina, Carles Xavier Raventós Busquets, Jacques Planas Morin, Anna Santamaria Margalef
Funding agency: Instituto de Salud Carlos III
Funding: 229500
Reference: RD12/0036/0035
Duration: 01/01/2013 - 30/06/2017

Alteraciones moleculares relacionadas con la progresión tumoral en el cáncer de endometrio Numero projecte extern: GCB 110333 REVE

IP: Jaume Reventós Puigjaner
Collaborators: Eva Colas Ortega, Marta Rebull Santamaria
Funding agency: Asociación Española Contra el Cáncer
Funding: 1200000
Reference: AECC- GCB 110333 REVE
Duration: 01/08/2011 - 28/07/2016

Identification of new molecules and mechanisms of myometrial infiltration and early diagnosis to improve survival in endometrial cancer

IP: Jaume Reventós Puigjaner
Collaborators: Maria Asuncion Perez Benavente, Eva Colas Ortega, Josep Castellví Vives
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 133100
Reference: SAF2011-26548
Duration: 01/01/2012 - 31/12/2014